Integrated diagnosis and treatment expert consensus for myasthenia gravis based on characteristics of Shanghai style traditional Chinese medicine

SHENG Zhaoyuan; CHEN Jian; YING Rujiong; DONG Yun; SHEN Jie

doi:10.16305/j.1007-1334.2024.08

您当前的位置：

首页 >

文章列表页 >

Integrated diagnosis and treatment expert consensus for myasthenia gravis based on characteristics of Shanghai style traditional Chinese medicine

更新时间：2024-07-04

- Integrated diagnosis and treatment expert consensus for myasthenia gravis based on characteristics of Shanghai style traditional Chinese medicine
- Shanghai Journal of Traditional Chinese Medicine Vol. 58, Issue 增刊1, Pages: 41-47(2024)
- 作者机构：
  
  上海中医药大学附属上海市中西医结合医院（上海 200082）
- 作者简介：
- 基金信息：
- DOI：10.16305/j.1007-1334.2024.08
  CLC：
- Published：10 June 2024，
  
  Received：25 April 2024，
- 稿件说明：
扫描看全文
盛昭园,陈建,应汝炯,等.基于海派中医特色的重症肌无力一体化综合诊疗专家共识[J].上海中医药杂志,2024,58(增刊1):41-47.

SHENG Zhaoyuan,CHEN Jian,YING Rujiong,et al.Integrated diagnosis and treatment expert consensus for myasthenia gravis based on characteristics of Shanghai style traditional Chinese medicine[J].Shanghai Journal of Traditional Chinese Medicine,2024,58(增刊1):41-47.
盛昭园,陈建,应汝炯,等.基于海派中医特色的重症肌无力一体化综合诊疗专家共识[J].上海中医药杂志,2024,58(增刊1):41-47. DOI： 10.16305/j.1007-1334.2024.08.

SHENG Zhaoyuan,CHEN Jian,YING Rujiong,et al.Integrated diagnosis and treatment expert consensus for myasthenia gravis based on characteristics of Shanghai style traditional Chinese medicine[J].Shanghai Journal of Traditional Chinese Medicine,2024,58(增刊1):41-47. DOI： 10.16305/j.1007-1334.2024.08.

摘要

Abstract

关键词

重症肌无力虚损病中西医结合诊断与治疗专家共识

Keywords

myasthenia gravisdeficiency lesion diseaseintegration of traditional Chinese and Western medicinediagnosis and treatmentexpert consensus

references

LAZARIDIS K， TZARTOS S J. Autoantibody specificities in myasthenia gravis； implications for improved diagnostics and therapeutics ［J］. Front Immunol， 2020， 11： 212.

VINCENT A.Unravelling the pathogenesis of myasthenia gravis［J］.Nat Rev Immunol， 2002， 2（10）： 797-804.

GILHUS N E. Myasthenia gravis［J］. N Engl J Med， 2016， 375（26）： 2570-2581.

TANIVSKA N， NOVITNI G，SAZDOVA-BURNESKA S，et al.Myasthenia gravis and associated diseases［J］. Open Access Maced J Med Sci， 2018， 6（3）： 472-478.

NARAYANASWAMI P， SANDERS D B， WOLFE G， et al.International Consensus Guidance for Management of Myasthenia Gravis：2020 Update ［J］. Neurology， 2021， 96（3）： 114-122.

常婷.中国重症肌无力诊断和治疗指南（2020版）［J］.中国神经免疫学和神经病学杂志， 2021， 28（1）： 1-12.

赵思佳，郭俊，李柱一.重症肌无力的治疗进展［J］.中国临床医生杂志， 2021， 49（6）： 649-652.

CHEN J， TIAN D C， ZHANG C， et al. Incidence， mortality， and economic burden of myasthenia gravis in China： A nationwide population-based study［J］.Lancet Reg Health West Pac， 2020， 5：100063.

李柱一，常婷.重症肌无力的诊断与治疗［J］.中华神经科杂志， 2022， 55（3）： 238-247.

HELDAL A T，OWE J F，GILHUS N E， et al.Seropositive myasthenia gravis：a nationwide epidemiologic study［J］.Neurology， 2009， 73（2）： 150-151.

HUANG X，LI Y，FENG H， et al.Clinical characteristics of juvenile myasthenia gravis in southern China［J］. Front Neurol， 2018， 9： 77.

JrHOWARD J F，UTSUGISAWA K， BENATAR M， et al.Safety and efficacy of eculizumab in antiacetylcholine receptor antibody-positive refractory generalised myasthenia gravis（REGAIN）：a phase 3，randomised，double blind，placebo controlled，multicentre study［J］.Lancet Neurol， 2017， 16（12）： 976-986.

ABBAS A E.A new testament for the followers of thymic epithelial tumors［J］. Innovations （Phila）， 2020， 15（3）： 211-224.

MUPPIDI S，UTSUGISAWA K，BENATAR M，et al.Long-term safety and efficacy of eculizumab in generalized myasthenia gravis ［J］.Muscle Nerve， 2019， 60（1）： 14-24.

DHILLON S.Eculizumab：A review in generalized myasthenia gravis［J］.Drugs， 2018， 78（3）： 367-376.

ANDERSEN H，MANTEGAZZA R，WANG J J，et al.Eculizumab improves fatigue in refractory generalized myasthenia gravis ［J］. Qual Life Res， 2019， 28（8）： 2247-2254.

HEWETT K， SANDERS D B， GROVE R A， et al.Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis［J］. Neurology， 2018， 90（16）： e1425-e1434.

JrHOWARD J F，BRIL V，BURNS T M，et al.Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis［J］ .Neurology， 2019， 92（23）： e2661-e2673.

HOWARD J F，BRIL V，VU T， et al.Safety，efficacy，and tolerability of efgartigimod in patients with generalized myasthenia gravis（ADAPT）：a multicentre，randomised，placebocontrolled，phase 3 trial［J］. Lancet Neurol， 2021， 20（7）： 526.

LANDON-CARDINAL O，FRIEDMAN D，GUIGUET M，et al.Efficacy of rituximab in refractory generalized anti-AChR myasthenia gravis［J］.J Neuromuscul Dis， 2018， 5（2）： 241-249.

GENG Y，DONG J，ZHOU Q. Rapid improvement of muscle weakness post-thymectomy indicates good long-term neurological outcome in patients with ocular myasthenia gravis［J］. Eur J Neurol， 2019， 26（11）： 1421-1423．

GONZALEZ R，RIQUELME U A，FUENTEALBA S M，et al.Results of extended transsternal thymectomy for Myasthenia gravis.Experience with 58 patients［J］. Rev Med Chile， 2018， 146（4）： 460-469．

SCHNEIDER-GOLD C，KRENZER M，KLINKER E，et al.Immunoadsorption versus plasma exchange versus combination for treatment of myasthenic deterioration［J］. Ther Adv Neurolog Dis， 2016， 9（4）： 297-303．

DEGUCHI K，MATSUZONO K，NAKANO Y，et al.A case of antiMuSK antibody-positive myasthenia gravis successfully treated with outpatient periodic weekly blood purification therapy［J］. Int Med， 2018， 57（10）： 1455-1458．

KHLER W，BUCKA C，KLINGEL R. A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis［J］. J Clin Apheresis， 2011， 26（6）： 347-355.

张伯礼，薛博瑜. 中医内科学［M］.北京：人民卫生出版社：311.

董秀娟.重症肌无力中医证治的文献资料整理研究［D］. 广州：广州中医药大学，2012.

唐飞舟. 邓铁涛教授五脏相关学说与推拿针药结合治疗重症肌无力的初步探讨［D］. 广州：广州中医药大学，2007.

林海雄，王晓彤，杨伟钦，等.基于数据挖掘的国医大师邓铁涛治疗重症肌无力辨治规律探究［J］. 辽宁中医杂志，2017， 44（12）： 2526⁃2529.

王敬卿，顾勤.周仲瑛教授治疗痿证经验［J］. 中国中医药信息杂志，2001， 8（1）： 77⁃78.

姜雄，何前松. 况时祥从“毒”论治重症肌无力的临床经验介绍［J］.江苏中医药，2016， 48（8）： 19⁃21.

刘畅，赫群.针灸治疗重症肌无力型上胞下垂55例［J］.实用中医药杂志，2017， 33（11）： 1306-1307．

徐兴华，代东良，方晓丽.“温通针法”针刺风池穴为主治疗眼肌型重症肌无力30例［J］.中国针灸， 2016， 36 （9）： 939．

杨俊红，杨丽丽，陈英哲，等.中药联合电针治疗重症肌无力62例的临床疗效观察［J］.中医临床研究， 2016， 8（26）： 67-68．

徐化金，高学军. 温针合梅花针治疗重症肌无力眼肌型36例［J］. 河北中医， 2001， 23（1）： 47．

盛昭园，刘杰，戴梦，等. 滚针治疗重症肌无力临床应用探讨［J］. 浙江中医杂志， 2021， 56（10）： 755-756.

康丽萍，杨云英，崔晓演，等. 中医外治法干预重症肌无力患者的临床结局评价研究［J］. 广州中医药大学学报，2020， 37（5）： 833-837．

Views

下载量

CSCD

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Expert consensus on clinical diagnosis and treatment of myelosuppression in ovarian cancer with integrated Chinese and Western medicine

Expert consensus on self‑management of TCM rehabilitation in myasthenia gravis patients

Expert consensus on whole process management model of integrated traditional Chinese and Western medicine for myasthenia gravis

Expert consensus on integrated traditional Chinese and western medicine in the treatment of early⁃stage Parkinson’s disease （2021）

Shanghai expert consensus on "whole period" diagnosis and reatment of ovarian cancer with integrated traditional Chinese and Western medicine

Related Author

LI He

RU Dan

ZHOU Yan

ZHANG Xu

DING Chenhuan

YU Chaoqin

ZHANG Tingting

XU Lianwei

Related Institution

Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

The First Affiliated Hospital of Naval Medical University （Changhai Hospital of Shanghai）

Yueyang Hospital of Integrated Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Shanghai TCM⁃Integrated Hospital of Shanghai University of Traditional Chinese Medicine

⁰